Healthcare -
Biotechnology - NASDAQ - US
$ 3.99
0.251 %
$ 258 M
Market Cap
-2.37
P/E
INZY - CASH FROM INVESTING ACTIVITIES
Cash from Investing Activities INZY - Inozyme Pharma, Inc.
67 M
LAST VALUE
279.48%
2 YEAR CAGR
58.44%
5 YEAR CAGR
0.00%
10 YEAR CAGR